Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 3 h ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Worth a look: purchases of $10K+ and sales of $250K+ not reported under a pre-arranged trading plan.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade
The CFO of Arthur J. Gallagher sold $1.44M of Arthur J. Gallagher shares. The filing does not indicate a pre-arranged trading plan.
Lately at Arthur J. Gallagher & Co.: it reported its results on Oct 29; the stock is up 8% in 30 days; insiders made no purchase ($10K+) and 10 large sales ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 16 · filed 2 days later
Since the trade −5.6% · S&P 500 −6.8% · to Nov 20
A Spyglass Pharma director paid $32K out of pocket for Spyglass Pharma shares.
Lately at Spyglass Pharma: the stock fell 11% in one session on Nov 10 with press coverage; it reported its results on Nov 12; the stock is up 10% in 30 days.
Insider buying
Traded Nov 16 · filed 2 days later
Since the trade +9.2% · S&P 500 −6.8% · to Nov 20
Bought 36% below the 52-week high, RSI 43, 14% under its 200-day average, 13 points behind the S&P 500 over 3 months
A major shareholder of Empire Petroleum paid $24K out of pocket for Empire Petroleum shares.
Lately at Empire Petroleum: the stock rose 21% in one session on Nov 6; it reported its results on Nov 16; the stock is down 22% in 30 days.
Insider buying
Traded Nov 17 · filed 1 day later
Since the trade −4.0% · S&P 500 −5.8% · to Nov 20
Bought within 4% of the 52-week low, RSI 30, 14% under its 200-day average, 20 points behind the S&P 500 over 3 months
A Global Water Resources director paid $31K out of pocket for Global Water Resources shares.
Lately at Global Water Resources: it reported its results on Nov 3; the stock is down 16% in 30 days; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Traded Nov 16 – Nov 17, 2026 · largest single transaction ~$21.6MNot reported under a pre-arranged trading plan
Lately at Roivant Sciences: it reported its results on Nov 9; the stock is up 5% in 30 days; insiders made no purchase ($10K+) and 22 large sales ($250K+, not pre-arranged) in 90 days.
Nov 16, 2026~$21.6M · 550K sh @ $39.17
DetailsOfficial recordNov 17, 2026~$20.1M · 526K sh @ $38.24
DetailsOfficial recordInsider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −3.3% · S&P 500 −6.8% · to Nov 20
Constellation Brands's Reporting person sold $21.8M of Constellation Brands shares. The filing does not indicate a pre-arranged trading plan.
Lately at Constellation Brands: the stock is up 7% in 30 days; insiders made no purchase ($10K+) and 13 large sales ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 16 · filed 2 days later
Since the trade −17.5% · S&P 500 −6.8% · to Nov 20
Bought 49% below the 52-week high, RSI 65, 3% under its 200-day average, 20 points ahead of the S&P 500 over 3 months
A Playboy director paid $31K out of pocket for Playboy shares.
Lately at Playboy: it reported its results on Nov 5; the stock is 58% below its 12-month high; insiders made 8 purchases ($10K+) and 16 large sales ($250K+, not pre-arranged) in 90 days.
Traded Nov 16 – Nov 17, 2026 · largest single transaction ~$3.11MNot reported under a pre-arranged trading plan
Lately at Roivant Sciences: it reported its results on Nov 9; the stock is up 5% in 30 days; insiders made no purchase ($10K+) and 22 large sales ($250K+, not pre-arranged) in 90 days.
Nov 16, 2026~$3.11M · 79K sh @ $39.17
DetailsOfficial recordNov 17, 2026~$2.9M · 76K sh @ $38.24
DetailsOfficial recordTraded Nov 16 – Nov 17, 2026 · largest single transaction ~$3.11MNot reported under a pre-arranged trading plan
Lately at Roivant Sciences: it reported its results on Nov 9; the stock is up 5% in 30 days; insiders made no purchase ($10K+) and 22 large sales ($250K+, not pre-arranged) in 90 days.
Nov 16, 2026~$3.11M · 79K sh @ $39.17
DetailsOfficial recordNov 17, 2026~$2.9M · 76K sh @ $38.24
DetailsOfficial recordInsider buying
Traded Nov 16 · filed 2 days later
Since the trade −6.1% · S&P 500 −6.8% · to Nov 20
Bought 18% below the 52-week high, RSI 56, 11% above its 200-day average
A Mammoth Energy Services director paid $15K out of pocket for Mammoth Energy Services shares. Shares held went up 6% with this purchase.
Lately at Mammoth Energy Services: it changed a top executive or board member on Nov 13; the stock is up 7% in 30 days; insiders made 2 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 17 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −2.3% · S&P 500 −5.8% · to Nov 20
The CFO of International Seaways sold $1.02M of International Seaways shares. The filing does not indicate a pre-arranged trading plan.
Lately at International Seaways, Inc.: it reported its results on Nov 5; the stock is down 13% in 30 days; insiders made no purchase ($10K+) and 18 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 18 · filed the same day
A CME officer told the SEC about a plan to sell $1.26M of CME shares around Nov 18, 2026. The shares were not acquired as compensation.
Lately at CME Group: it reported its results on Oct 21; insiders made no purchase ($10K+) and 6 large sales ($250K+, not pre-arranged) in 90 days.
Traded Nov 16, 2026 · largest single transaction ~$22K
Lately at Eurodry: the stock is down 30% in 30 days; insiders made 10 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Nov 16, 2026~$22K · 575 sh @ $37.45
DetailsOfficial recordNov 16, 2026~$22K · 575 sh @ $37.45
DetailsOfficial recordInsider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −12.0% · S&P 500 −6.8% · to Nov 20
A major shareholder of Loar sold $1.7M of Loar shares. The filing does not indicate a pre-arranged trading plan.
Lately at Loar: it reported its results on Nov 5; insiders made no purchase ($10K+) and 10 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 18 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −2.2% · S&P 500 −5.5% · to Nov 20
The CEO of Renasant sold $695K of Renasant shares. The filing does not indicate a pre-arranged trading plan.
Lately at Renasant Corp.: it reported its results on Oct 27; insiders made 1 purchase ($10K+) and 1 large sale ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 18 · filed the same day
Spyglass Pharma's L.P., Insider told the SEC about a plan to sell $1.17M of Spyglass Pharma shares around Nov 18, 2026. The shares were not acquired as compensation. That is 0.1% of all Spyglass Pharma shares.
Lately at Spyglass Pharma: the stock fell 11% in one session on Nov 10 with press coverage; it reported its results on Nov 12; the stock is up 10% in 30 days.